VX-770 News
Most Popular VX-770 Story
Vertex dazzles analysts with landmark Ph3 CF results
Excited biotech analysts this morning heralded outstanding results for Vertex's Phase III study of the cystic fibrosis drug VX-770 as a breakthrough of historic proportions. Investigators say that Read more...
Latest Headlines
- October 28, 2011
- October 19, 2011
- March 29, 2011
- February 23, 2011
- February 20, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
